Transition to Ambulatory Bariatric Surgery (TABS) Trial
Recruiting
Who can join
Ages 25 to 55 · All sexes
Full eligibility criteria
Inclusion Criteria: * BMI ≤ 60 kg/m2 * Primary Sleeve gastrectomy or Gastric Bypass, * Undergoing bariatric surgery at sponsor site Exclusion Criteria: * Type 1 Diabetes * Myocardial Infarction * Unstable Angina or Heart Failure * Prior Stroke * Solid organ transplantation * Systemic glucocorticoid prior 28 days * Severe Obstructive Sleep Apnea * Uncontrolled Hypertension (Systolic \> 150, Diastolic \> 90) * Untreated Hyperthyroidism * Chronic Kidney Disease (EGFR \< 60) * Current anticoagulant use, * Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months \> 8.5%) * Chronic opioid use * Insulin dependence. * Need for extended venous thromboembolic event prophylaxis, * \> 1 lifetime bariatric surgery (revisional or conversion bariatric surgery) * Patient lives \> 130 miles from the hospital. * Tobacco use in last 12 months * Desire to become pregnant or active pregnancy * Prisoners * Unable or unwilling to follow-up * Unable to understand or provide consent
About the study
This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.
What is being tested
- Same Day Discharge (other)
Sponsor: Vanderbilt University Medical Center · Participants: 200 · Started: Oct 1, 2026
Contact the study team
- Jason Samuels · Phone: (615) 322 - 4504
Official record on ClinicalTrials.gov — NCT07011628
Locations in the U.S.
| Tennessee | Vanderbilt University Medical Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.